Skip to main content
. 2011 Sep 7;2011(9):CD001817. doi: 10.1002/14651858.CD001817.pub2

Hoffman 2000.

Methods Blinding of randomization: yes 
 Blinding of intervention: yes 
 Complete follow up: yes 
 Blinding of outcome: yes 
 Randomized controlled trial, parallel design 
 Washout period: 3‐5 days after last dose of furosemide
Participants Patients entered into the study: n=33 
 The need for mechanical ventilation was not used as a criterion. 
 Entry criteria: Infants with postconceptional age 26‐33 weeks, chronic lung disease (oxygen dependency beyond 28 days), enteral feeding, decision by the attending to prescribe oral diuretic therapy. 
 Exclusion criteria: renal anomalies known, i.v. fluids, furosemide or early portion of a course of dexamethasone (0.1 to 0.5 mg/kg/day)
Interventions Thiazide and spironolactone vs thiazide and placebo 
 Patients were randomly allocated to receive either chlorothiazide 20 mg/kg/day with spironolactone 3 mg/kg/day for 2 weeks (N=17), or chlorothiazide 20 mg/kg/day with placebo for 2 weeks (N=16).
Outcomes Main outcome: need for electrolyte supplementation; secondary outcome: pulmonary function, serum electrolyte concentration
Notes Dynamic pulmonary mechanics were measured using an esophageal balloon.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Randomized controlled trial, parallel design
Allocation concealment (selection bias) Low risk Blinding of randomization: yes
Blinding (performance bias and detection bias) 
 All outcomes Low risk Blinding of intervention: yes 
 Blinding of outcome: yes
Incomplete outcome data (attrition bias) 
 All outcomes Low risk Complete follow up: yes